BioSpace News Archive

BiondVax Universal Flu Vaccine Patent Granted in India

The patent belongs to BiondVax’s portfolio family titled “Multimeric Multi-Epitope Influenza Vaccines” and has now been granted in over 30 countries.

January 2, 2018
·
3 min read
Business

Allurion Technologies Announces New Roles Within Its Leadership Team And Senior Management Hires

Dr. Shantanu Gaur will serve as Chief Executive Officer effective January 1, 2018.

January 2, 2018
·
5 min read
ASLAN Pharma’s Abstract on Varlitinib Wins Best Poster at ESMO Asia 2017

ASLAN Pharma today announced that an abstract presented at ESMO Asia 2017 on data from its Phase 2 clinical trial of varlitinib in metastatic HER2-positive breast cancer patients won the Best Poster Award in the breast cancer, metastatic category.

January 2, 2018
·
2 min read
Business

Predictive Technology Group Appoints Dr. Michael Dey To Board Of Directors

In addition to serving as a PRED Board Member, Dr. Dey will continue as Chief Executive Officer of Predicitive Therapeutics, Inc., a wholly owned subsidiary of PRED.

January 2, 2018
·
3 min read
Recipharm Acquires Remaining Shares in Nitin Lifesciences Ltd

Recipharm today announces that it has reached an agreement to acquire the remaining 26 per cent of the shares of Nitin Lifesciences Limited which were owned by members of the founding Sobti family.

January 2, 2018
·
2 min read
Policy

Selecta Biosciences Announces FDA Acceptance of IND Application for LMB-100 and SVP-Rapamycin Combination Therapy

SVP-Rapamycin is Selecta’s proprietary, clinical-stage anti-drug antibody (ADA) prevention and immune tolerance technology.

January 2, 2018
·
7 min read
Biotech Bay

Biotricity Announces Expansion of Bioflux Sales Force and Pilot Sites

Biometric Remote Monitoring Company Actively Prepares for Product Launch by Hiring Sales and Expanding Business Development Initiatives

January 2, 2018
·
4 min read
Business

Vericel Initiates Collaboration With Innovative Cellular Therapeutics

Under the terms of the agreement, ICT will develop and distribute MACI, Epicel, ixmyelocel-T and Carticel in Greater China, South Korea, Singapore, and other countries in the region.

January 2, 2018
·
7 min read
GN Store Nord: Transactions in Relation to Share Buyback Program - Jan. 2 2018

The share buyback program has been initiated in order to reduce the company’s share capital and to cover obligations under the long-term incentive program.

January 2, 2018
·
2 min read
Veloxis Announces the Total Number of Shares and Voting Rights in the Company as of 31 December 2017

Here’s a table that provides the total number of shares and voting rights in Veloxis as of 31 December 2017.

January 2, 2018
·
1 min read